Literature DB >> 20693959

In vitro fertilization and stem cell harvesting from human embryos: the law and practice in the United States.

C Christopher Hook1.   

Abstract

The challenges before science and medicine are these: science must explore the natural world as thoroughly as possible, while still honoring, protecting, serving and preserving the subject of its investigations, and the human beings for whom it is a tool; medicine must confront disease and disability as effectively as possible, while also honoring, protecting, and preserving those beings for whom it serves - all of those beings, not just some, or even most, at the potential expense of others. These goals are challenged by embryo-destructive human embryonic stem cell research. The human embryo is a human being as clearly defined by embryology, and as such should be protected by the codes governing human subject research. However, because of the "potential" benefits offered by pluripotent stem cells, coupled with abortion politics and a very poorly regulated infertility industry, United States governmental advisory commissions and the scientific, medical, and political communities have attempted to define away the humanity of the human embryo, with a few notable exceptions. Because infertility treatments in the United States are poorly regulated, there are large numbers of supernumerary embryos in cryopreservation. However, only a tiny portion of these will ever be potentially available for research, and thus are not a realistic source of the cells necessary to provide treatments to the millions who might benefit from proposed stem cell based therapies. Cloning will not be the answer either, given the millions of women who must be exploited to provide sufficient numbers of eggs to generate the cloned cell lines. Moreover, the disposition decisions parents must make for their extra embryos are often agonizing, and not uncommonly change. The use of supernumerary embryos as a source for human embryonic stem cells is unethical, will never be a sufficient source for the medical treatments expected from stem cell research, and is often a source of great distress for the conceiving parents. The United States experience is not a positive model for other countries to emulate.

Entities:  

Mesh:

Year:  2010        PMID: 20693959

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  2 in total

1.  Impedance of novel therapeutic technologies: the case of stem cells.

Authors:  David G Zacharias; Timothy J Nelson; Paul S Mueller; C Christopher Hook
Journal:  Clin Transl Sci       Date:  2012-06-28       Impact factor: 4.689

2.  Isolation of muscle-derived stem/progenitor cells based on adhesion characteristics to collagen-coated surfaces.

Authors:  Mitra Lavasani; Aiping Lu; Seth D Thompson; Paul D Robbins; Johnny Huard; Laura J Niedernhofer
Journal:  Methods Mol Biol       Date:  2013
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.